U.S. Department of Health and Human Services U.S. Department of Health and Human Services www.hhs.gov
National Institutes of Health - Research Portfolio Online Reporting Tool (RePORT) Website Reports Data and Analyses Of NIH Research and Development Activities
Site Map
 
Home Home Frequently Requested Reports Frequently Requested Reports Reports Reports Category Spending Reports NIH CRISP (Computer Retrieval of Information on Scientific Projects) – Search Funded Scientific Projects CRISP Glossary Glossary FAQs FAQS Links LINKS Request Report
NIH National Institutes of Health Research Portfolio Online Reporting Tool (RePORT) Website Reports Data and Analyses Of NIH Research and Development Activities

NIH Begins New Process to Report Detailed Funding Information - NIH made public the results of a new process for providing detailed funding information for 215 major areas of research.more...
RePORT Tutorial
NIH Biennial Report
Category Spending
Research, Condition, and Disease Categorization (RCDC)
Quick Links
NIH Extramural Data Book
PowerPoint - 12.5 MB PDF ~ 5MBWeb Version
spacer img
PubMed Central
spacer img
PubMed
spacer img
Current Operating Year NIH Budget
spacer img
FY 2009 President's Budget Request
spacer img
NIH Extramural Awards By State and Foreign Site
spacer img
NIH Extramural Awards by State and Congressional District
spacer img
spacer img
Data on New Investigators
spacer img
Estimates of Funding for Various Diseases, Conditions, Research Areas
spacer img
NIH Roadmap for Medical Research
spacer img
Award Data for Individual Organizations
  Home > Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) > Project Listing by Category  

Project Listing by Category

 Research, Condition, and Disease Categorization Process Website
Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis NIDA 1K23DA020383-01A1 Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users TAYLOR, LYNN MIRIAM HOSPITAL RI $179,212
Hepatitis NIDDK 5F32DK074348-02 Hepatoxicity in an African HIV Treatment Cohort HOFFMANN, CHRISTOPHER JOHNS HOPKINS UNIVERSITY MD $53,992
Hepatitis NIDA 1R01DA021550-01A2 HCV Transmission among Young IDUs in NYC EDLIN, BRIAN SUNY DOWNSTATE MEDICAL CENTER NY $834,452
Hepatitis NIGMS 5R01GM060620-09 Mechanism of RNA Helicase Activity by DExH/D Proteins PYLE, ANNA YALE UNIVERSITY CT $239,995
Hepatitis NCI 5R01CA040489-23 Pathogenesis of Hepatitis B Virus in Transgenic Mice CHISARI, FRANCIS SCRIPPS RESEARCH INSTITUTE CA $792,726
Hepatitis NIAID 5R01AI047365-09 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $362,764
Hepatitis NIAID 2R01AI020001-25 Pathogenesis of Liver Disease in Hepatitis CHISARI, FRANCIS SCRIPPS RESEARCH INSTITUTE CA $685,357
Hepatitis NIMH 5R01MH067990-05 Fronto-Striatal Dysfunction in IFNa-Induced Depression MILLER, ANDREW EMORY UNIVERSITY GA $261,130
Hepatitis NIMH 5K05MH069124-05 Pathology and Treatment of Cytokine-Induced Depression MILLER, ANDREW EMORY UNIVERSITY GA $116,932
Hepatitis NIAID 5R01AI064844-03 Role of Hepatitis B virus X protein in HBV replication. BOUCHARD, MICHAEL DREXEL UNIVERSITY PA $315,019
Hepatitis NIAID 5R01AI057591-04 Alteration of innate immunity by HCV core HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $282,356
Hepatitis NIAID 5R37AI047367-09 HCV-specific T cell response WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $541,702
Hepatitis NIDDK 5F32DK067781-03 Cis- and Trans-acting Factors in HCV Gene Expression BRADRICK, SHELTON DUKE UNIVERSITY NC $52,048
Hepatitis NIMH 5R01MH079752-02 Role of evolving white matter damage in neurocognitive effects of HIV and HCV JERNIGAN, TERRY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $347,625
Hepatitis NIAID 5R01AI072613-02 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $414,473
Hepatitis NIAID 5R01AI067417-03 Molecular Modulation of HBV Capsid Assembly ZLOTNICK, ADAM UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $345,885
Hepatitis NIAID 5R01AI026522-30 Structure and Replication of Hepatitis Delta Virus TAYLOR, JOHN INSTITUTE FOR CANCER RESEARCH PA $632,726
Hepatitis NIAID 5R01AI065985-03 Defining NS4B Function in Hepatitis C Virus Replication BLIGHT, KERIL WASHINGTON UNIVERSITY MO $289,575
Hepatitis NIDDK 5R01DK064223-05 HCV NS5A: Molecular Virology and Antiviral Target GLENN, JEFFREY STANFORD UNIVERSITY CA $261,667
Hepatitis NIMH 5R01MH070553-04 Cytokine-CRH Interactions in IFN-alfa-Induced Depression RAISON, CHARLES EMORY UNIVERSITY GA $326,412
Hepatitis NIAID 5R01AI020720-25 Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines MILICH, DAVID VACCINE RESEARCH INSTITUTE OF SAN DIEGO CA $747,395
Hepatitis NIAID 5R37AI028731-19 Noncarbohydrate Approaches to AntiAIDS Nuleosides LIOTTA, DENNIS EMORY UNIVERSITY GA $324,651
Hepatitis NIAID 5R01AI061158-04 Mechanisms of Innate and Adaptive Immunity In HCV NELSON, DAVID UNIVERSITY OF FLORIDA FL $304,514
Hepatitis NIAID 5R21AI067449-02 Prevalence and Epidemiology of Hepatitis E Virus in the United States NELSON, KENRAD JOHNS HOPKINS UNIVERSITY MD $105,948
Hepatitis NIAID 5R01AI043453-11 Mechanisms of Hepadnavirus Assembly and Replication HU, JIANMING PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $297,279
Hepatitis NIAID 5R21AI072170-02 Roles of host RNA binding proteins in virus replication NAGY, PETER UNIVERSITY OF KENTUCKY KY $200,124
Hepatitis NIAID 5R01AI069000-03 Roles for microRNA-122 in hepatitis C virus RNA amplification SARNOW, PETER STANFORD UNIVERSITY CA $295,433
Hepatitis NIAID 5R01AI030070-16 Regulation of Hepatitis B Virus Transcription MCLACHLAN, ALAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $512,408
Hepatitis NCI 5R01CA023931-30 Analyzing Hepatitis B Virus Pathogenesis ISOM, HARRIET PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $325,985
Hepatitis NIAID 5U01AI064002-04 Chemoprophylaxis for HIV Prevention in Men GRANT, ROBERT J. DAVID GLADSTONE INSTITUTES CA $5,141,967
Hepatitis NIAID 5R01AI069142-02 Immune Mechanisms of HCV Persistence and Pathogenesis SUN, JIAREN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $333,295
Hepatitis NIDA 5R01DA011598-10 Nutritional Status In HIV Hispanic Drug Abusers FORRESTER, JANET TUFTS UNIVERSITY BOSTON MA $660,216
Hepatitis NIMH 5K23MH071177-04 Adherence to HCV Treatment in HCV and HCV/HIV Patients WEISS, JEFFREY MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $148,791
Hepatitis NCI 5R01CA056533-16 Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis SCHNEIDER, ROBERT NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $423,021
Hepatitis NIAID 2R01AI050611-05A2 A Chicken Model to Study Hepatitis E Virus Pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $315,867
Hepatitis NCI 5R01CA115625-02 Proteomic Analysis of Serum in Liver Cancer GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY DC $340,569
Hepatitis NIAID 5R01AI060018-04 Mechanisms of Avian Hepadnavirus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN MADISON WI $332,989
Hepatitis NIAID 1R21AI076706-01 Impact of NK Cell Immune Pressures on HCV Evolution and Viral Fitness ALTFELD, MARCUS MASSACHUSETTS GENERAL HOSPITAL MA $263,250
Hepatitis NIDDK 5R01DK076852-02 The Lysosomal-Mitochondrial Axis in Nonalcoholic Fatty Liver Disease FELDSTEIN, ARIEL CLEVELAND CLINIC LERNER COL/MED-CWRU OH $279,351
Hepatitis NIAID 1R21AI076834-01 Cell Culture System for Hepatitis C Virus Genotype 1a DI BISCEGLIE, ADRIAN SAINT LOUIS UNIVERSITY MO $183,750
Hepatitis NIDDK 5K24DK070528-04 Mentorship in Liver Disease SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $117,084
Hepatitis NCI 5R01CA109733-04 Molecular Target(s) for Interruption of HBV Infection LI, JISU RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $214,052
Hepatitis NIAID 5R01AI058740-05 GB Virus type C Natural History, Epidemiology, HIV Interaction STAPLETON, JACK UNIVERSITY OF IOWA IA $617,141
Hepatitis NIAID 5R21AI067455-02 Resolution of Acute Hepatitis B Virus Infections in Chimpanzees LANFORD, ROBERT SOUTHWEST FOUNDATION FOR BIOMEDICAL RES TX $222,579
Hepatitis NIAID 5R01AI069285-02 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $126,887
Hepatitis NIDDK 5R01DK066939-05 Modulation of HCV Gene Expression BRANCH, ANDREA MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $370,132
Hepatitis NIDDK 5R01DK070877-03 Immunoglobulin Allotypes in Hepatitis C Virus Infection PANDEY, JANARDAN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $186,896
Hepatitis NIDDK 5R01DK066802-05 PATHOPHYSIOLOGY OF CRYOGLOBULINEMIC GLOMERULONEPHRITIS ALPERS, CHARLES UNIVERSITY OF WASHINGTON WA $352,173
Hepatitis NIDDK 5K01DK067207-04 Genetic Epidemiology of NAFLD and T2DM KAO, WEN HONG JOHNS HOPKINS UNIVERSITY MD $128,958
Hepatitis NIAID 5R01AI069952-03 Statistical methods for modeling hepatitis C fibrosis progression BACCHETTI, PETER UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $178,477
Hepatitis NHLBI 5R01HL073921-05 Pathophysiology of IFN-alpha-induced Sleep Disturbances MILLER, ANDREW EMORY UNIVERSITY GA $290,143
Hepatitis NCI 1R01CA126807-01A1 HCV genetic variation and hepatocellular carcinoma TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $274,523
Hepatitis NIAID 5R01AI068090-03 Understanding Immunopathogenesis of Hepatitis B Virus BARON, JODY UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $367,527
Hepatitis NIDDK 1R01DK073897-01A2 Iron-Induced Changes in Liver That Predispose to Malignancy ISOM, HARRIET PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $245,493
Hepatitis NIDDK 1R01DK075990-01A2 Nutrition and Nonalcoholic Fatty Liver Disease LI, ZHIPING JOHNS HOPKINS UNIVERSITY MD $348,500
Hepatitis NIDA 5R01DA010164-12 The Logics for HIV Risk Among Homeless Heroin Injectors BOURGOIS, PHILIPPE UNIVERSITY OF PENNSYLVANIA PA $360,811
Hepatitis NIDDK 5R01DK053933-09 CTL Effector Mechanisms in Adenoviral Hepatitis THIELE, DWAIN UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $267,446
Hepatitis NIDDK 5R01DK068361-03 Role of immature DC in host defense against HCV ANTHONY, DONALD CASE WESTERN RESERVE UNIVERSITY OH $241,111
Hepatitis NIAID 1R01AI073335-01A2 RNA-dependent RNA Synthesis by the Hepatitis C Virus KAO, CHENG TEXAS A&M UNIVERSITY SYSTEM TX $287,713
Hepatitis NCCAM 1R21AT002895-01A2 Mechanisms of Action of Silymarin for Hepatitis C POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $247,685
Hepatitis NIAID 5R01AI018641-26 Hepadnavirus Infections and Liver Cancer MASON, WILLIAM INSTITUTE FOR CANCER RESEARCH PA $562,151
Hepatitis NIDDK 5F32DK079860-02 Characterization of the Assembly and Egress Pathway of Hepatitis C Virus SHOHDY, NADIM ROCKEFELLER UNIVERSITY NY $49,646
Hepatitis FIC 5R01TW006972-04 Risk Factors for HIV-1 infection Among Young Thai Men RANGSIN, RAM PHRAMONGKUTKLAO COLLEGE OF MEDICINE THAIL $51,202
Hepatitis NIDA 1K23DA022454-01A1 Directly Observed Hepatitis C Treatment in Methadone Clinics LITWIN, ALAIN YESHIVA UNIVERSITY NY $178,897
Hepatitis NIDDK 5R03DK075416-02 Relationship of metabolic abnormalities to hepatic steatosis in HIV STERLING, RICHARD VIRGINIA COMMONWEALTH UNIVERSITY VA $72,290
Hepatitis NIDDK 5R01DK075397-02 Potential Mechanisms of Glucagon-like peptide-1 in Fatty Liver Disease ANANIA, FRANK EMORY UNIVERSITY GA $253,399
Hepatitis NCI 1K25CA127524-01A1 Biomarker Discovery for Hepatitis C Progression using Machine Learning Techniques SPRATT, HEIDI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $126,357
Hepatitis NIAID 5R01AI073299-02 Mechanism and in vivo anti-HBV study of a novel class of non-nucleoside compounds CHENG, YUNG-CHI YALE UNIVERSITY CT $365,024
Hepatitis NCI 1R21CA127046-01A1 Analysis of the Cytokine-Immunological Model of a Cancer-Related Symptom Cluster STEEL, JENNIFER UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $204,525
Hepatitis NIDDK 1R01DK078686-01A1 Genetic and epigenetic regulation of Hepatitis B contributes to liver cancer TORBENSON, MICHAEL JOHNS HOPKINS UNIVERSITY MD $348,500
Hepatitis NIDDK 5R21DK077575-02 Liver Disease Associated with HCV/HIV Coinfection Due to TRAIL VLAHAKIS, STACEY MAYO CLINIC COLL OF MEDICINE, ROCHESTER MN $181,300
Hepatitis NIDDK 1R01DK077704-01A2 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $328,313
Hepatitis NIDDK 5K23DK062116-04 Hyperinsulinemia and Insulin Resistance in Fatty Liver ABDELMALEK, MANAL DUKE UNIVERSITY NC $123,390
Hepatitis NIDDK 5K24DK002727-09 Cirrhosis and its complications GARCIA-TSAO, GUADALUPE YALE UNIVERSITY CT $156,104
Hepatitis NCI 5R21CA122523-02 Role of metallothioneins in hepatocellular carcinoma JACOB, SAMSON OHIO STATE UNIVERSITY OH $150,000
Hepatitis NIAID 5R01AI047347-10 Regulation of human T-cell immunity to HCV antigens ECKELS, DAVID UNIVERSITY OF UTAH UT $455,271
Hepatitis NCI 5R01CA112053-04 Mechanisms of the HBX-interacting protein (HBXIP) REED, JOHN BURNHAM INSTITUTE FOR MEDICAL RESEARCH CA $357,678
Hepatitis NIDDK 5R01DK069859-03 Genes Related to HCC Progression in LD and DD Transplant FISHER, ROBERT VIRGINIA COMMONWEALTH UNIVERSITY VA $482,550
Hepatitis NIAID 5R01AI065256-03 Antiretroviral Therapy and the Hepatitis C Virus SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $686,648
Hepatitis NIAID 5R01AI066209-03 Viral Host Interactions in Hepatitis C GRETCH, DAVID UNIVERSITY OF WASHINGTON WA $408,680
Hepatitis NIDDK 5K23DK064909-05 Complications of Cirrhosis in American Patients MARRERO, JORGE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $132,300
Hepatitis NHLBI 5R01HL079381-05 Neutralizing Antibodies to Hepatitis C FOUNG, STEVEN STANFORD UNIVERSITY CA $589,711
Hepatitis NIAID 1R43AI068239-01A1 An Orally Delivered Hepatitis B Vaccine HOWARD, JOHN APPLIED BIOTECHNOLOGY INSTITUTE CA $295,171
Hepatitis NIAID 5R01AI050798-05 Functional analysis of hepatitis C virus glycoproteins MCKEATING, JANE UNIVERSITY OF BIRMINGHAM UK $200,490
Hepatitis NIDDK 5R01DK069757-04 Pathophysiology and Characterisation of NAFLD CHARLTON, MICHAEL MAYO CLINIC COLL OF MEDICINE, ROCHESTER MN $294,078
Hepatitis NCI 5R01CA055578-13 Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B YEN, TIEN-SZE NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $245,449
Hepatitis NIDA 5K01DA017179-05 HCV Treatment Cost-Effectiveness in 3 IDU Populations SCHACKMAN, BRUCE WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $169,492
Hepatitis NIDDK 5R01DK072187-02 Genetics of Nonalcoholic Fatty Liver Disease (NAFLD) ERICKSON, SANDRA NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $308,896
Hepatitis NCI 5U01AI035039-16 MULTICENTER AIDS COHORT STUDY PHAIR, JOHN HOWARD BROWN HEALTH CENTER IL $104,638
Hepatitis NIAID 5U01AI035039-16 MULTICENTER AIDS COHORT STUDY PHAIR, JOHN HOWARD BROWN HEALTH CENTER IL $3,497,128
Hepatitis NIAID 5R01AI057504-04 Regulatory mechanisms of HBV X gene Transcription TAKADA, SHINAKO UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $316,025
Hepatitis NIAID 5R01AI072012-02 New Antiviral Therapies for Hepatitis C Infection HERMANN, THOMAS UNIVERSITY OF CALIFORNIA SAN DIEGO CA $367,061
Hepatitis NCI 2R42CA121506-02 HCC diagnostics defined by fucosylated serum biomarkers MEHTA, ANAND IMMUNOTOPE, INC. PA $564,986
Hepatitis NIDDK 1R43DK080549-01 TGFb1 Receptor Inhibitors for Liver Fibrosis CAI, WEIZHONG ANGION BIOMEDICA CORPORATION NY $255,501
Hepatitis NIAID 5R21AI066957-02 Immunity of neoantigen response in HCV, HIV, and HCV-HIV ANTHONY, DONALD CASE WESTERN RESERVE UNIVERSITY OH $189,456
Hepatitis NCI 1R41CA132397-01 Small Molecule Inhibitors of HBV/HCV Induced Liver Diseases DHEER, SURENDRA SONITU PHARMACEUTICALS, LLC PA $168,000
Hepatitis NHLBI 2R44HL076946-02 Single Well MPCR Donor Screen to ID Blood Pathogens RANKEN, RAYMOND IBIS BIOSCIENCES, INC. CA $338,153
Hepatitis NIDDK 2R44DK074205-02 Novel diagnostic and safety biomarkers of liver injury and hepatotoxicity SVETLOV, STANISLAV BANYAN BIOMARKERS, INC. FL $422,483
Hepatitis NIDDK 5R01DK053792-08 Liver Disease in Obesity DIEHL, ANNA MAE DUKE UNIVERSITY NC $336,285
Hepatitis NIDDK 5R01DK075128-03 MR Imaging of Non-Alcoholic Fatty Liver Disease SIRLIN, CLAUDE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $463,288
Hepatitis NCI 5R03CA128048-02 Development of a vaccine against Helicobacter pylori to prevent gastric cancer BEGUE, RODOLFO CHILDREN'S HOSPITAL (NEW ORLEANS) LA $77,950
Hepatitis NIAID 5R01AI068885-02 Novel Therapeutic Approaches for Eliminating Hepatitis B Virus DNAs and RNAs MCCAFFREY, ANTON UNIVERSITY OF IOWA IA $361,744
Hepatitis NCI 5R01CA037232-24 HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA ROGLER, CHARLES YESHIVA UNIVERSITY NY $483,550
Hepatitis NIBIB 5R01EB005964-03 Monitoring Hepatitis and Cirrhosis by 23Na MRS/MRI BANSAL, NAVIN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $380,683
Hepatitis NIAID 1R43AI074214-01A1 An RNAi Trojan Horse for treatment of hepatitis C. JOHNSTON, BRIAN SOMAGENICS, INC. CA $295,743
Hepatitis NIDDK 5R01DK037948-22 OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE KLEIN, SAMUEL WASHINGTON UNIVERSITY MO $430,721
Hepatitis NIAID 1R13AI077295-01 Hepatic Inflammation and Immunity 2008 LEMON, STANLEY UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $20,000
Hepatitis NIDDK 1R13AI077295-01 Hepatic Inflammation and Immunity 2008 LEMON, STANLEY UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $5,000
Hepatitis NIAID 5R43AI072780-02 Broadly Neutralizing MAbs against Hepatitis C Virus OLSON, WILLIAM PROGENICS PHARMACEUTICALS, INC. NY $287,309
Hepatitis NIMH 5R01MH073433-04 Neurobehavioral Effects of HIV & Host Genetics in China HEATON, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $645,840
Hepatitis NICHD 5U01HD040470-08 New Orleans Adolescent Medicine Trials Unit ABDALIAN, SUE TULANE UNIVERSITY OF LOUISIANA LA $581,030
Hepatitis NIDDK 5K23DK077568-02 Kidney Disease in HIV-Hepatitis C Virus Co-Infection WYATT, CHRISTINA MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $129,225
Hepatitis NIAID 5R01AI068769-03 QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS RAY, RANJIT SAINT LOUIS UNIVERSITY MO $315,056
Hepatitis NCI 5R01CA067529-14 Helicobacter induced hepatitis and tumorigenesis FOX, JAMES MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $341,346
Hepatitis NCI 5R21CA122317-02 Development of Glypican-3 as a biomarker for hepatocellular carcinoma SO, SAMUEL STANFORD UNIVERSITY CA $146,400
Hepatitis NCI 5R01CA085888-09 Malignant Complications of Chronic HCV LOFFREDO, CHRISTOPHER GEORGETOWN UNIVERSITY DC $297,351
Hepatitis NIAAA 5R01AA014257-04 Lymphocyte recruitment in alcoholic hepatitis ADAMS, DAVID UNIVERSITY OF BIRMINGHAM UK $153,605
Hepatitis NIAAA 5R01AA016171-03 Quantitative Proteomic Analysis of Alcoholic Fatty Liver Biogenesis WU, CHRISTINE UNIVERSITY OF COLORADO DENVER CO $293,024
Hepatitis NIDDK 5R01DK066754-05 Impaired T cell function by HCV core HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $282,304
Hepatitis NIDA 5R01DA022030-03 Electronic Information System to Enhance Practice at an Opioid Treatment Program BROWN, LAWRENCE ADDICTION RESEARCH AND TREATMENT CORP NY $179,626
Hepatitis NIDDK 5K24DK078154-02 Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring Program EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $149,057
Hepatitis NIAID 5R01AI049574-08 GBV-B: A Small Primate Model for Hepatitis C Infection LANFORD, ROBERT SOUTHWEST FOUNDATION FOR BIOMEDICAL RES TX $311,605
Hepatitis NIAID 5R01AI060449-05 Liver Disease and HIV-HBV Coinfection in the HAART era THIO, CHLOE JOHNS HOPKINS UNIVERSITY MD $587,069
Hepatitis NIAAA 5R21AA016316-02 Alcoholic Hepatitis: Molecular Mechanisms SAFE, STEPHEN TEXAS A&M UNIVERSITY SYSTEM TX $169,918
Hepatitis NIMH 1R21MH078740-01A2 Enhancing HCV Treatment Decisions in HIV Co-Infected Patients and Their Providers WAGNER, GLENN RAND CORPORATION CA $238,108
Hepatitis NIDA 1R21DA023893-01A1 Mediation Effect of Network Function on Transition to Injection Drug Use LIU, HONGJIE VIRGINIA COMMONWEALTH UNIVERSITY VA $215,840
Hepatitis NIDA 5R01DA022177-02 Opioids, HIV/HCV and Host Cell Innate Immunity HO, WENZHE CHILDREN'S HOSPITAL OF PHILADELPHIA PA $402,864
Hepatitis NIDA 1K01DA024654-01 Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients PILLAI, SATISH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $180,360
Hepatitis NIAID 2R01AI052065-05A2 HCV and HIV Progression in Women on HAART KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $533,057
Hepatitis NIDDK 5R21DK074891-02 Novel model of HCV infection of humanized liver in immunocompetent rats WU, GEORGE UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $145,040
Hepatitis NCI 5R01CA111427-05 Early antibody markers of HCC FEITELSON, MARK TEMPLE UNIVERSITY PA $276,457
Hepatitis NIAID 5R01AI064489-03 The Role of Proteasomes in Viral RNA Translation PILIPENKO, EVGENY UNIVERSITY OF CHICAGO IL $361,698
Hepatitis NIDA 5R03DA022128-02 Wyoming Meth Use and AIDS Risk: Exploring Rural Culture and Context (WyMAR) BOWEN, ANNE UNIVERSITY OF WYOMING WY $70,070
Hepatitis NCI 5R01CA113663-04 Hepatitis B ESL Education for Chinese TAYLOR, VICTORIA FRED HUTCHINSON CANCER RESEARCH CENTER WA $400,747
Hepatitis NCI 5K01CA107092-05 Hepatocellular carcinoma: targeting HCV replication LINDENBACH, BRETT YALE UNIVERSITY CT $162,378
Hepatitis NCI 5R37CA035711-25 Pathogenesis, Immunodiagnosis and Therapy of HCC WANDS, JACK RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $320,011
Hepatitis NIDDK 5R01DK070844-03 Transplantation of Reduced-Size Fatty Livers ZHONG, ZHI MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $256,328
Hepatitis NCI 5R21CA128391-02 Randomized trial of doxorubicin beads for arterial embolization of hepatocellular BROWN, KAREN SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $187,000
Hepatitis NIAID 5R37AI041980-12 NUCLEOSIDES WITH DUAL ANTI-HIV AND HBV ACTIVITY SCHINAZI, RAYMOND EMORY UNIVERSITY GA $210,146
Hepatitis NCI 1R25CA129042-01A1 Asian American Liver Cancer Education Program in Maryland JUON, HEE-SOON JOHNS HOPKINS UNIVERSITY MD $276,609
Hepatitis NIDA 5R01DA020841-03 Hepatitis Care Coordination in Methadone Treatment PERLMAN, DAVID BETH ISRAEL MEDICAL CTR (NEW YORK) NY $354,372
Hepatitis NIAID 5K23AI065319-04 Thrombocytopenia & HIV/HCV: Risk Factors & Treatment MARKS, KRISTEN WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $131,490
Hepatitis NIAID 5K08AI069989-02 An in vitro system to study antiviral strategies against Hepatitis C virus WYLES, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $105,570
Hepatitis NIDA 5R01DA020781-03 Hepatitis Care Coordination in Methadone Treatment MASSON, CARMEN UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $331,144
Hepatitis NIAID 1R01AI074667-01A1 Mechanism of Hepatitis E Virus Replication and Pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $390,031
Hepatitis NIDDK 5R01DK074718-02 Evaluation of MRI & MR Spectroscopic Markers in Non-Alcoholic Fatty Liver Disease QAYYUM, ALIYA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $217,273
Hepatitis NIAID 5R01AI047519-10 Cellular immunity - outcome hepatitis C virus infection CHANG, KYONG-MI UNIVERSITY OF PENNSYLVANIA PA $304,162
Hepatitis NCI 5R21CA125321-02 Variation in NTP use by the HCV polymerase and response to therapy TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $147,000
Hepatitis NIDDK 1R01DK080711-01 Hepatitis C Virus Quasispecies in the Resistance to Antiviral Therapy FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $294,000
Hepatitis NIDDK 5R21DK078100-02 Ribavirin Pharmacokinetics, Race and HCV Treatment HOWELL, CHARLES UNIVERSITY OF MARYLAND BALTIMORE MD $181,912
Hepatitis NCRR 5R01RR006555-17 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $307,697
Hepatitis NIAID 5K08AI072191-02 Mechanisms of T cell dysfunction in Hepatitis C virus persistence RADZIEWICZ, HENRY EMORY UNIVERSITY GA $128,250
Hepatitis NIDDK 5R01DK078857-02 Interferon modulation of cellular microRNAs in the Hepatitis C antiviral defense DAVID, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $279,351
Hepatitis NIDDK 5R01DK075274-02 Mouse model of chronic viral hepatitis CRISPE, IAN UNIVERSITY OF ROCHESTER NY $306,368
Hepatitis NIDDK 5R01DK071560-04 Innate Immune Responses During Therapy for Chronic HCV ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $270,459
Hepatitis NIDDK 1K23DK080888-01 Biological Determinants of Steatohepatitis after Adolescent Bariatric Surgery XANTHAKOS, STAVRA CHILDREN'S HOSPITAL MED CTR (CINCINNATI) OH $176,472
Hepatitis NIDDK 5K23DK074396-03 Non-Alcoholic Fatty Liver Disease Ethnicity and Hepatic Metabolism BROWNING, JEFFREY UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $132,570
Hepatitis NIAID 5R01AI069939-03 HIV-Hepatitis C Virus Interactions and Pathogenesis CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $375,067
Hepatitis NIDDK 5U01DK061713-07 Pathogenesis, prognosis, and treatment of NAFLD patients DIEHL, ANNA MAE DUKE UNIVERSITY NC $238,069
Hepatitis NIAID 5R01AI061684-05 Dendritic Cell mediated induction of Anti-HCV immunity BHARDWAJ, NINA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $571,176
Hepatitis NIAID 1K99AI077800-01 Studies of hepatitis C virus polarized cell entry and host factor requirements EVANS, MATTHEW ROCKEFELLER UNIVERSITY NY $90,000
Hepatitis NIDDK 5R01DK068450-05 Dietary factors in the pathogenesis of steatohepatitis MAHER, JACQUELYN UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $330,824
Hepatitis NIDDK 5U01DK061731-07 CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS SANYAL, ARUN VIRGINIA COMMONWEALTH UNIVERSITY VA $241,103
Hepatitis NICHD 1P01HD057247-01 0003 Molecular Characterization of Liver Gene Transfer and Its Oncogenic Potential GAO, GUANG-PING% UNIVERSITY OF PENNSYLVANIA PA $122,883
Hepatitis NIDDK 5K24DK066144-05 Mentoring Junior Faculty: Hepatitis C Clinical Research FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $139,317
Hepatitis NIDA 5R01DA016017-06 Acute Hepatitis C Infection in Young Injectors PAGE-SHAFER, KIMBERLY UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $466,965
Hepatitis NIDA 5R01DA016159-05 Acute HCV Infection in Injection Drug Users EDLIN, BRIAN WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $650,470
Hepatitis NIAID 5R21AI072180-02 Towards Developing type 1a HCV cell culture model DASGUPTA, ASIM UNIVERSITY OF CALIFORNIA LOS ANGELES CA $188,843
Hepatitis NIEHS 5R01ES005116-18 Biological Markers of Aflatoxin Exposure SANTELLA, REGINA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $337,642
Hepatitis NIAID 5R01AI064463-03 Kupffer Cells in Liver Immunopathology CRISPE, IAN UNIVERSITY OF ROCHESTER NY $371,495
Hepatitis NCI 5R01CA122295-02 Androgen Receptor Roles in Liver Cancer Incidence and Progression CHANG, CHAWNSHANG UNIVERSITY OF ROCHESTER NY $292,600
Hepatitis NIDA 5K01DA023365-02 Dynamic Modeling of the HCV Epidemic in IDU HAHN, JUDITH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $165,521
Hepatitis NIDA 5R01DA016078-07 The Progression of Hepatitis C Among IDUs THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $712,636
Hepatitis NIGMS 5R01GM023750-33 Biologic Studies with Peroxisome Proliferators and PPARs REDDY, JANARDAN NORTHWESTERN UNIVERSITY IL $480,009
Hepatitis NIDDK 5U01DK062452-07 Biliary Atresia clinical Research Consortium SHEPHERD, ROSS WASHINGTON UNIVERSITY MO $191,800
Hepatitis NIDDK 5U01DK062497-07 Clinical center for biliary atresia: Etiopathogenesis and clinical outcome BEZERRA, JORGE CHILDREN'S HOSPITAL MED CTR (CINCINNATI) OH $238,994
Hepatitis NIDDK 5U01DK062453-07 Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis SOKOL, RONALD UNIVERSITY OF COLORADO DENVER CO $486,984
Hepatitis NIDDK 5U01DK062500-07 Biliary Atresia Clinical Research Consortium ROSENTHAL, PHILIP UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $140,857
Hepatitis NIDDK 5U01DK062481-07 Mid-Atlantic BANH Consortium Site HABER, BARBARA CHILDREN'S HOSPITAL OF PHILADELPHIA PA $159,546
Hepatitis NIAID 5R01AI071068-03 RNAi for the Treatment of Viral Hepatitis KAY, MARK STANFORD UNIVERSITY CA $377,376
Hepatitis NIAID 5U01AI066735-04 Partnership for developing broad-spectrum microbicides PHILLIPS, DAVID POPULATION COUNCIL NY $468,242
Hepatitis NIAID 5R03AI069090-02 Role of mitochondrial core protein in Hepatitis C Virus pathogenesis OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $95,648
Hepatitis NIAAA 5R01AA016231-03 Lifetime Drinking Patterns & HCV Treatment Outcomes RUSSELL, MARCIA PACIFIC INSTITUTE FOR RES AND EVALUATION MD $389,191
Hepatitis NIAID 2R01AI040696-11A2 Regulation of HBV Replication by the Immune System GUIDOTTI, LUCA SCRIPPS RESEARCH INSTITUTE CA $473,750
Hepatitis NIAID 5K01AI073193-02 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs LINAS, BENJAMIN MASSACHUSETTS GENERAL HOSPITAL MA $135,815
Hepatitis NIDA 5R01DA019383-04 Staying Safe: Long-Term Injection Drug Users Who Have Avoided HIV & Hepatitis C FRIEDMAN, SAMUEL NATIONAL DEVELOPMENT & RES INSTITUTES NY $599,233
Hepatitis NIDA 5R01DA019841-09 Natural History of Hepatitis C Infection in HIV Disease COTTON, DEBORAH BOSTON UNIVERSITY MEDICAL CAMPUS MA $866,282
Hepatitis NCI 5R01CA120206-03 Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer MEHTA, ANAND DREXEL UNIVERSITY PA $317,565
Hepatitis NCI 5R13CA095919-07 Workshops on Viral Pathogenesis and Oncogenesis FAN, HUNG UNIVERSITY OF CALIFORNIA IRVINE CA $9,000
Hepatitis NIAID 5K01AI070001-02 Risk factors and prediction of liver disease in HIV/HCV LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $133,029
Hepatitis NIGMS 1R01GM081346-01A1 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $272,880
Hepatitis NIAID 1R01AI074982-01A1 Molecular Mechanism of Hepadnavirus Persistence HU, JIANMING PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $300,541
Hepatitis NIAAA 2R37AA009300-13A2 Lipid Aldehyde and Ethanol Induced Liver Damage PETERSEN, DENNIS UNIVERSITY OF COLORADO DENVER CO $521,760
Hepatitis NIDDK 5U01DK062466-07 Biliary Atresia Clinical Research Consortium: Pittsburgh SHNEIDER, BENJAMIN CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS PA $243,147
Hepatitis NIDA 5K23DA022143-03 Substance Abuse, HIV and HCV Treatments to Improve Health Outcomes in Drug Users BRUCE, ROBERT YALE UNIVERSITY CT $174,077
Hepatitis NIAID 5R43AI074255-02 Multiplexed mRNA quanitification using self-circularizing RNA probes KAZAKOV, SERGEI SOMAGENICS, INC. CA $299,965
Hepatitis NIDDK 5K08DK076598-02 The Pathogenesis of Steatosis in Hepatitis C Genotype 3 Infection JHAVERI, RAVI DUKE UNIVERSITY NC $124,308
Hepatitis NIDDK 5R21DK073649-02 MRI Quantification & Display of Hepatic Fat in Hepatitis C & NAFLD Patients HUSSAIN, HERO UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $186,200
Hepatitis NIAID 2R01AI060389-07 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $383,372
Hepatitis NIDDK 1R01DK075681-01A2 Genetic Epidemiology of Metabolic Diseases of Obesity BORECKI, INGRID WASHINGTON UNIVERSITY MO $515,631
Hepatitis NIAID 1R01AI075099-01A1 Role of HCV p7 and NS2 in infectious virus production RICE, CHARLES ROCKEFELLER UNIVERSITY NY $420,000
Hepatitis NIDDK 1R01DK074673-01A2 Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos KHALILI, MANDANA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $457,981
Hepatitis NIDDK 5R01DK074515-02 Role of HCV Sequence Variation in Pathology TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $318,528
Hepatitis NCI 2P01CA022443-31 0011 Mechanisms of Hepatitis B Virus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN MADISON WI $240,843
Hepatitis NCI 2P01CA022443-31 9003 Instrumentation LOEB, DANIEL UNIVERSITY OF WISCONSIN MADISON WI $56,901
Hepatitis NIAID 1R21AI065535-01A2 Developing an in vitro system for HCV propagation RAY, RATNA SAINT LOUIS UNIVERSITY MO $183,135
Hepatitis NIAID 5K23AI065630-04 Molecular Basis of Interferon Response in HCV JAIN, MAMTA UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $124,200
Hepatitis NIDA 1K23DA023467-01A1 Chronic Pain and Substance Use in Patients with Hepatitis C MORASCO, BENJAMIN OREGON HEALTH AND SCIENCE UNIVERSITY OR $165,533
Hepatitis NCI 1K22CA128866-01A1 HEPATOCELLULAR CARCINOMA AND HEPATITIS C: E2 MOLECULAR MECHANISMS BUCK, MARTINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $148,770
Hepatitis NIAID 5K23AI066943-04 Gender Effects of HIV and HCV on lipodystrophy, glucose disorders, and steatosis TIEN, PHYLLIS UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $121,770
Hepatitis NCI 1R21CA133976-01A2 Hepatitis B virus immune escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $145,789
Hepatitis NCI 5K07CA107085-04 Can Stress Management Improve Vaccine Immune Response MCGREGOR, BONNIE FRED HUTCHINSON CANCER RESEARCH CENTER WA $129,195
Hepatitis NIAID 1K08AI075031-01A1 The Pathogenesis of Autoimmunity in Hepatitis C Virus Infection CHARLES, EDGAR ROCKEFELLER UNIVERSITY NY $140,400
Hepatitis NIAID 1R21AI073928-01A2 Development of a plant-derived virus-like particle vaccine against SARS-CoV HUANG, ZHONG ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $187,701
Hepatitis NIDA 1R21DA023521-01A1 An Arts Intervention for Drug-Using Homeless Youth NYAMATHI, ADELINE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $192,500
Hepatitis NINDS 5K23NS051244-02 Relationship of Cytokines to Cognitive Functions in HCV HILSABECK, ROBIN UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $167,980
Hepatitis NIDA 5R01DA024565-02 Mechanisms of Hepatitis C Virus Evolution RAY, STUART JOHNS HOPKINS UNIVERSITY MD $503,137
Hepatitis NIAID 5R01AI070101-03 Mechanisms of hepatitis C virus persistence GRAKOUI, ARASH EMORY UNIVERSITY GA $401,835
Hepatitis NINR 5K23NR010408-02 The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge PIGEON, WILFRED UNIVERSITY OF ROCHESTER NY $129,951
Hepatitis NIDA 5R01DA019829-04 Epidemiology of HIV and Hepatitis C Among Injecting Drug Users in Tijuana STRATHDEE, STEFFANIE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $706,524
Hepatitis NIAID 5R01AI049730-08 DEVELOPMENT OF THE HBcAG AS A VACCINE CARRIER PLATFORM MILICH, DAVID VACCINE RESEARCH INSTITUTE OF SAN DIEGO CA $531,825
Hepatitis NIAID 5R01AI049168-08 HCV Replication and Immune Response in HIV Coinfection GRETCH, DAVID UNIVERSITY OF WASHINGTON WA $568,445
Hepatitis NIDA 5R01DA003018-26 Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity ROTH, MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $564,473
Hepatitis NCI 5U01CA084951-10 Early Detection of Liver Cancer BLOCK, TIMOTHY DREXEL UNIVERSITY PA $424,009
Hepatitis NIEHS 5R01ES014662-02 Serum Organochlorine Levels and Primary Liver Cancer: A Nested Case-Control Study ENGEL, LAWRENCE SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $763,744
Hepatitis NCI 5R01CA120372-03 Phase I Clinical Translation Trial of Oncolytic rVSV-F Virotherapy for HCC WOO, SAVIO MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $595,625
Hepatitis NIDDK 5K08DK076565-02 Bias in Retransplantation Survival Models: Selection Criteria and Hepatitis C BIGGINS, SCOTT UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $121,770
Hepatitis NIAID 5R43AI072802-02 Identification of an inhibitor of microRNA-122 in liver FREIER, SUSAN ISIS PHARMACEUTICALS, INC. CA $132,885
Hepatitis NIAID 5R43AI068566-02 Novel gp41 Immunogens for HIV-1 Vaccines WHALEN, ROBERT MAXYGEN, INC. CA $298,727
Hepatitis NIEHS 5R21ES015954-02 Activating liver carcinogens in yeast by expressing CYP450 polymorphisms FASULLO, MICHAEL ORDWAY RESEARCH INSTITUTE, INC. NY $217,438
Hepatitis NIMH 5K23MH071181-05 HIV/HCV: Neuropsychiatric and Neurophysiologic Features RYAN, ELIZABETH MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $155,044
Hepatitis NIDDK 5R01DK073192-03 Liver Regeneration in the Transplant Setting OLTHOFF, KIM UNIVERSITY OF PENNSYLVANIA PA $154,566
Hepatitis NIDDK 5R01DK066917-05 Innate-like hepatic CD1d-reative NKT cells:Liver Disease EXLEY, MARK BETH ISRAEL DEACONESS MEDICAL CENTER MA $197,460
Hepatitis NIDDK 5R01DK072017-04 Obesity and Hepatic Steatosis PAGLIASSOTTI, MICHAEL COLORADO STATE UNIVERSITY-FORT COLLINS CO $238,722
Hepatitis NCI 1R43CA133993-01 Immune Response Modification for Treatment of Hepatocellular Carcinoma FAIRMAN, JEFF JUVARIS BIOTHERAPEUTICS, INC. CA $255,467
Hepatitis NIDA 5R01DA013806-09 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $499,538
Hepatitis NIDA 5K23DA018623-05 Pre-Chemotherapeutic Care of HCV Infected Drug Users FISHBEIN, DAWN MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $175,986
Hepatitis NIAID 1R43AI075829-01A1 Generation of novel HCV drugs through engineereing of the cssA gene ELHAMMER, AKE AUREOGEN BIOSCIENCES, INC. MI $300,000
Hepatitis NCCAM 5U01AT003571-03 Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease AFDHAL, NEZAM BETH ISRAEL DEACONESS MEDICAL CENTER MA $275,862
Hepatitis NIDDK 5U01AT003571-03 Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease AFDHAL, NEZAM BETH ISRAEL DEACONESS MEDICAL CENTER MA $82,500
Hepatitis NCCAM 5U01AT003560-03 A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $273,536
Hepatitis NIDDK 5U01AT003560-03 A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $71,088
Hepatitis NIAID 1R41AI072859-01A2 HCV Genotyping and Drug Resistance Testing by ESI/MS BLYN, LAWRENCE IBIS BIOSCIENCES, INC. CA $290,535
Hepatitis NCRR 5K23RR022206-03 HCV Kinetics and Determinants of Relapse SCOTT, JOHN UNIVERSITY OF WASHINGTON WA $153,792
Hepatitis NIAID 5R43AI072785-02 Development of a Proplylactic HCV Vaccine WHITACRE, DAVID VLP BIOTECH, INC. CA $300,000
Hepatitis NIAID 5R21AI077012-02 Novel Molecules that Define Viral Persistence BROOKS, DAVID SCRIPPS RESEARCH INSTITUTE CA $34,254
Hepatitis NIAID 1R43AI077123-01A1 Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection CUCONATI, ANDREA PHARMABRIDGE, INC. PA $240,146
Hepatitis NCI 5R01CA100579-04 Protein Kinase Pathways in Cytokine-Signaling PLATANIAS, LEONIDAS NORTHWESTERN UNIVERSITY IL $250,281
Hepatitis NIDDK 5K24DK072036-04 Racial Disparities in Liver Diseases HOWELL, CHARLES UNIVERSITY OF MARYLAND BALTIMORE MD $194,250
Hepatitis NIAID 5R21AI070769-02 Hepatitis C virus infection and lipoproteins LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $215,575
123
 

Return To Top

    Download Readers: Download Adobe PDF Reader   Download Microsoft PowerPoint Viewer   Download Microsoft Word Viewer   Download Microsoft Excel Viewer
We would like to hear from you. Click here to provide your feedback Home  |   Frequently Requested Reports  |   Reports  |   Category Spending  |   CRISP  |   Glossary  |   FAQs  |   Links  |   Contact Us
Site Map  |   Accessibility Statement  |   Privacy Statement  |   Disclaimer  |   FOIA  |   Help Downloading Files
O E R logo - link to Office of Extramural Research N I H logo - link to the National Institutes of Health H H S logo - link to U. S. Department of Health and Human Services USA.gov logo - link to USA.gov Grants.gov logo - link to Grants.gov
Page Last Updated on January 24, 2008

This site is best viewed with Internet Explorer (6.0 or higher) or Mozilla Firefox (2.0).